If Dean does not report an AI request on the same day or within a day from when it occurred, he will lose ALL investor confidence and THEN the stock will truly tank. I, personally, would sell immediately and never look at the company again. And I'm sure many people would do the same.
I think Dean understands what it would do to his investor's trust if he were to hide an AI request.
I disagree. Any A1 request in a 510K application is a material event. Dean Jane’s has informed investors of each and every A1 event in the past. I see no need to suspect that that will change at this point in the FDA process. What is your basis for your statement, to think otherwise Mr. Sano?
Market Data 
Markets 
AI
